Login
$MCTA
$29.36 +$0.00 (0.0%) Close

Ownership

13F as of Q2 2026 · 16.2M shares outstanding

Who owns MCTA?

By type of holder
Institutions 0.3% Insiders 0.0% Everyone else 99.8%
Concentration Top 4 holders own 64.4%
Kit Wong 64.1% · UBS Group AG 0.2%
Institutional ownership
0.3%
-0.0 pts vs last qtr
Institutional holders
3
0 vs last qtr
Net shares bought
−700
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • UBS Group AG −700

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Charming Medical Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026
+5.3%
+2.61% a year
Each share's claim on the business
−5.0%
shrank without buying or selling a share
Diluted shares, split-adjusted
14.9M15.6M16.3M2024: 15.3M shares'242025: 15.3M shares'252026: 16.2M shares'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%
Quarterly turnover
0.8%
of institutional shares changed hands
Top 10 managers, median time held
2 quarters

Super Investors

Investment managers reporting MCTA on Form 13F
UG
UBS Group AG
Shares
24.2K
% of company
0.15%
Change vs last qtr
−700 (−2.8%)
Held since
Q4 '25
GC
Geode Capital Management, LLC
Shares
10.8K
% of company
0.07%
Change vs last qtr
Unchanged
Held since
Q4 '25

1 more super investors behind a free account

See every manager holding Charming Medical Ltd, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting MCTA on Form N-PORT; together they hold 0.0% of the company
No fund reports holding MCTA yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
KW
Kit Wong
5%+ holder13D · 69.3%
Shares
10.4M
% of company
64.09%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support